Cantitate/Preț
Produs
Total produse
Vezi coșul
Substance Use Disorders de Gerard Moeller

Substance Use Disorders: Primer On

Editat de Gerard Moeller, Mishka Terplan
en Limba Engleză Paperback – 9 dec 2020
Substance Use Disorders provides an overview of substance misuse and addresses the neurobiology, pharmacotherapy, and behavioural therapy management of substance use disorders from a clinical perspective. Examining the opioid epidemic to frame its discussion of the epidemiology of substance misuse, this book explores common barriers that prevent the implementation of effective treatment. Chapters discuss various aspects of substance use disorders, particularly opioids, alcohol, cannabis, and cocaine, to inform better conceptualization and management of these conditions. Part of the Primer On Psychiatry series, this book will provide a solid foundation for residents and fellows in psychiatry and addiction medicine and can also be used in clinical practice.
Citește tot Restrânge

Din seria Primer On

Preț: 53270 lei

Preț vechi: 64633 lei
-18%

Puncte Express: 799

Carte disponibilă

Livrare economică 18-23 septembrie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780190920197
ISBN-10: 019092019X
Pagini: 384
Dimensiuni: 251 x 175 x 23 mm
Greutate: 0.7 kg
Editura: Oxford University Press
Colecția OUP USA
Seria Primer On

Locul publicării:New York, United States

Notă biografică

F. Gerard "Gerry" Moeller, MD, is Director of the C. Kenneth and Dianne Wright Center for Clinical and Translational Research, and Associate Vice President for Clinical Research at Virginia Commonwealth University. He is also Director of the Institute for Drug and Alcohol Studies and Division Chair for Addiction Psychiatry. Awarded the C. Kenneth and Dianne Wright Distinguished Chair in Addiction Science, his research focuses on translational research on addictions, with a goal of developing novel treatments that reduce drug use and overdose. He is board certified in Psychiatry and Addiction Medicine.Mishka Terplan, MD, MPH, is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research, and advocacy interests lie along the intersections of reproductive and behavioral health. He is Associate Medical Director at Friends Research Institute and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmlineclinician for the National Clinical Consultation Center. He is also the Addiction Medicine Specialist for Virginia Medicaid and a consultant for the National Center on Substance Abuse and Child Welfare. Dr. Terplan has active has published over 100 peer-reviewed articles with emphasis on health disparities, stigma, and access to treatment.

Cuprins

  • Chapter 1: Epidemiology of Substance Use Disorders: Opioid Use Disorder Epidemic
  • Chapter 2: Epidemiology of Cannabis Use Disorder: Neural Substrates and Treatment
  • Chapter 3: Preclinical Models of Substance Use Disorder: Abuse Liability Assessment and Candidate Pharmacotherapy Evaluation
  • Chapter 4: Impulsivity and Drug-Seeking Behavior in Substance Misuse: A Preclinical Perspective
  • Chapter 5: Impulsivity and Cue Reactivity in Substance Misuse: Clinical Studies
  • Chapter 6: Stress and Substance Misuse
  • Chapter 7: Overview: Barriers and Advantages of Utilization of FDA Approved Medications for Substance Use Disorder
  • Chapter 8: Methadone for Opioid Use Disorder
  • Chapter 9: Use of Buprenorphine for the Treatment of Opioid Use Disorder
  • Chapter 10: Antagonist Treatment for Opioid Use Disorder: Development of Antagonist Treatment. Antagonists vs. Agonist Treatments Pros and Cons
  • Chapter 11: Pharmacotherapy for Opioid Use Disorders in Special Populations
  • Chapter 12: Pharmacology of Alcohol Use Disorder
  • Chapter 13: Pharmacotherapy for Smoking Cessation: Overview of Medications Including Over-the-Counter Nicotine Replacement Therapy, Bupropion and Varenicline
  • Chapter 14: What is "Evidence Based" Treatment?
  • Chapter 15: Evidence Based Behavioral Therapies for Substance Use Disorder
  • Chapter 16: Evidence Based Pharmacotherapy for Cocaine, Amphetamine, and Methamphetamine Use Disorder: Overview and History of Clinical Trials
  • Chapter 17: Evidence Based Pharmacotherapy for Alcohol Use Disorder
  • Chapter 18: Turn the Next Page: Envisioning the Future of Addiction Therapeutics